This suggests to us that, as is the standard now, when we use an anabolic agent, we can add in an antiresorptive such as alendronate, and see continued sustained reduction in fracture risk.
Patients with scleroderma-associated isolated pulmonary arterial hypertension (SSc-PAH) have a slightly higher mortality risk than patients SSc-PAH with concomitant interstitial lung disease.
Rheumatology specialists should be aware of the clinical features of SSc-PAH, as well as the tools available to facilitate a prompt, accurate diagnosis.